Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. G’s Marine Aquaculture is a specialized manufacturer of medicated fish foods and nutritional supplements tailored for the marine and freshwater aquarium industry. The company develops unique therapeutic delivery systems by infusing high-quality food sources, such as caviar and mysis shrimp, with pharmaceutical-grade medications to treat common aquatic ailments. Their product portfolio includes treatments for bacterial infections, internal and external parasites, and fungal outbreaks, designed to be ingested directly by sick organisms. Based in Florida, Dr. G's provides solutions that bridge the gap between clinical veterinary treatment and hobbyist aquarium maintenance. The company is widely recognized for its focus on high palatability and effective dosage delivery in aquatic environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. G’s Marine Aquaculture.